PolyPeptide Group is a Contract Development & Manufacturing Organization (CDMO) specializing in peptide and oligonucleotide-based active pharmaceutical ingredients (APIs). They offer services from pre-clinical to commercial stages, serving pharmaceutical and biotech companies. Their target audience includes companies developing therapies for widespread and rare diseases. PolyPeptide's unique selling proposition is its extensive experience and global network of GMP-certified facilities, providing high-quality peptide manufacturing with a focus on customer satisfaction and regulatory compliance[1][2][3]. This positions them as a preferred partner for companies seeking reliable peptide API development and manufacturing.